Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT)

SCales for Outcomes in PArkinson’s disease - Autonomic Dysfunction


Acronym: SCOPA-AUT

Authors: Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ

The SCOPA-AUT was developed to evaluate autonomic symptoms in patients with Parkinson’s disease as well as patients with Multiple System Atrophy (MSA). The scale is self-completed by patients and consists of 25 items assessing the following domains: gastrointestinal (7), urinary (6), cardiovascular (3), thermoregulatory (4), pupillomotor (1), and sexual (2 items for men and 2 items for women). 

The development of the SCOPA-AUT is part of a larger research project, the SCales for Outcomes in PArkinson’s disease (SCOPA), in which practical and clinimetric sound instruments for all relevant regions in PD are selected or developed. The SCOPA instruments were originally developed in the Dutch language. 

Original Publication View the Instrument (PDF)

Year Published: 2004

Scale Last Updated: Unchanged since publication

Assessment Type:  PRO

Estimated Time to Administer the Scale: 15-20 minutes

Available Translations:

  • Austria-German
  • Bulgarian
  • Canada-English
  • Canada-French
  • Chinese-Mandarin
  • Czech
  • Danish
  • Dutch
  • French
  • German
  • Greek
  • Hungarian
  • Israel-Hebrew
  • Israel-Arabic
  • Israel-Russian
  • Italian
  • Japanese
  • Korean
  • Norwegian
  • Polish
  • Spanish
  • Serbian
  • Swedish
  • Turkish
  • US-Spanish


Additional Scale Publications:

Bostantjopoulou S, Katsarou Z, Danglis I, Karakasis H, Milioni D, Falup-Pecurariu C. Self-reported autonomic symptoms in Parkinson's disease: properties of the SCOPA-AUT scale. Hippokratia 2016 Apr-Jun;20(2):115-120.

Kim JY, Song IU, Koh SB, Ahn TB, Kim SJ, Cheon SM, Cho JW, Kim YJ, Ma HI, Park MY, Baik JS, Lee PH, Chung SJ, Kim JM, Kim HJ, Sung YH, Kwon DY, Lee JH, Lee JY, Kim JS, Yun JY, Kim HJ, Hong JY, Kim MJ, Youn J, Kim JS, Oh ES, Yang HJ, Yoon WT, You S, Kwon KY, Park HE, Lee SY, Kim Y, Kim HT, Kim JS. Validation of the Korean version of the Scale for Outcomes in Parkinson’s disease-Autonomic. J Mov Disord 2017;10:29-34.

Matsushima M, Yabe I, Hirotani M, Kano T, Sasaki H. Reliability of the Japanese version of the scales for outcomes in Parkinson's disease-autonomic questionnaire. Clin Neurol Neurosurg. 2014 Sep;124:182-4

Mantarova SG, Velcheva IV, Georgieva SO, Stambolieva KI. Validation of the Bulgarian version of Scales for Outcomes in Parkinson's Disease - Autonomic (SCOPA-AUT-BG). Folia Med (Plovdiv). 2013 Jul-Dec;55(3-4):56-62.

Carod-Artal FJ, Ribeiro Lda S, Kummer W, Martinez-Martin P. Psychometric properties of the SCOPA-AUT Brazilian Portuguese version. Mov Disord. 2010 Jan 30;25(2):205-12.

Forjaz MJ, Ayala A, Rodriguez-Blazquez C, Frades-Payo B, Martinez-Martin P; Longitudinal Parkinson's Disease Patient Study, Estudio longitudinal de pacientes con enferedad de Parkinson- ELEP Group. Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis. Eur J Neurol. 2010 Feb;17(2):273-9.

Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, de Pedro-Cuesta J, Martinez-Martin P; Longitudinal Parkinson's Disease Patient Study, Estudio Longitudinal de Pacients con Enfermedad da Parkinson Group. Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT). Eur J Neurol. 2010 Feb;17(2):194-201

Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord. 2009 Apr 15;24(5):635-46.

 

 

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice